Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization
Jul
26
2023
Blue Gentian, LLC v. Tristar Prods., Inc. No. 2021-2316, 2021-2317, pending cite (Fed. Cir. June 9, 2023) Sheppard, Mullin, Richter & Hampton LLP
Jul
26
2023
Another Federal NIL Bill on the Horizon: Analyzing the Draft College Athlete Protection and Compensation Act Bradley Arant Boult Cummings LLP
Jul
25
2023
15 Rolex Counterfeiters Sentenced to up to 6.5 Years Prison in 300 Million RMB Counterfeit Case Schwegman, Lundberg & Woessner, P.A.
Jul
25
2023
PTAB Makes Significant Changes to Director Review Process Sheppard, Mullin, Richter & Hampton LLP
Jul
25
2023
Would The Patent Eligibility Restoration Act Strike The Right Balance? Foley & Lardner LLP
Jul
25
2023
No Laughing Matter: Comedian Sarah Silverman Sues Meta Platforms and OpenAI for Copyright Infringement Bradley Arant Boult Cummings LLP
Jul
24
2023
The Generative AI Revolution: Key Legal Considerations for the Consumer Products Industry ArentFox Schiff LLP
Jul
22
2023
Privacy Tip #366 – Tips for Protecting Your Privacy While Using Generative AI Robinson & Cole LLP
Jul
21
2023
Salazar v. AT&T Mobility LLC No. 21-2320 (Fed. Cir. Apr. 5, 2023) Sheppard, Mullin, Richter & Hampton LLP
Jul
21
2023
Split Decisions: Can a Complaint Serve as Knowledge of Indirect Infringement? Mintz
Jul
21
2023
I’m an Intellectual Property Attorney “In a Barbie World.” Ward and Smith, P.A.
Jul
21
2023
As Generative AI Training Lawsuits Mount, Some Providers Offer New Assurances Proskauer Rose LLP
Jul
21
2023
Hit a Nerve? Obviousness Inquiry Must Address Claims at Issue McDermott Will & Emery
Jul
20
2023
Reissue Boat Won’t Float: “Original Patent” Rule Sinks New Floating Grill Claims McDermott Will & Emery
Jul
20
2023
Battle of the Brands Epstein Becker & Green, P.C.
Jul
20
2023
China Standard Contract That Impacts Transferring Personal Information from China K&L Gates
Jul
20
2023
China’s State Administration for Market Regulation Releases Draft Anti-monopoly Guidelines in the Field of Standard Essential Patents for Comment Schwegman, Lundberg & Woessner, P.A.
Jul
20
2023
Speculative Injury from Rulemaking Petition Denial Doesn’t Confer Standing McDermott Will & Emery
Jul
19
2023
The GenAI Revolution: Key Legal Considerations for the Long-Term Care and Senior Living Industry ArentFox Schiff LLP
Jul
19
2023
Connecticut Passes Law Regarding State Use of AI and Amendments to Data Privacy Law Jackson Lewis P.C.
Jul
19
2023
Corporate Transparency Act Compliance for DAOs Is Unclear Polsinelli PC
Jul
19
2023
IP Toolbox Is Crucial In AI-Powered Drug Discovery Foley & Lardner LLP
Jul
18
2023
China’s Utility Model Grants Down 25% in First Half of 2023; Invention Patent Grants Up 10% Schwegman, Lundberg & Woessner, P.A.
Jul
18
2023
Intellectual Property and Artificial Intelligence Art
Jul
17
2023
USPTO Provides Updated Guidance on the Use of Applicant Admitted Prior Art Foley & Lardner LLP
Jul
17
2023
My Employees Are Using ChatGPT. What Now? Foley & Lardner LLP
Jul
17
2023
NCAA Issues NIL Edict: Play by Our Rules, Not State Laws Varnum LLP
Jul
15
2023
Whistleblowers and Trade Secrets: Does the DTSA Protect Confidential Data? Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins